Veterinary Vaccines Market 2025-2029
The veterinary vaccines market is forecasted to grow by USD 3378.3 mn during 2024-2029, accelerating at a CAGR of 6.2% during the forecast period. The report on the veterinary vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of animal diseases, growing pet ownership and humanization of pets, and expansion of livestock industry.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's veterinary vaccines market is segmented as below:
By Type
- Live attenuated
- Inactivated
- Recombinant
- DNA
- Toxoid
By Application
- Livestock
- Poultry
- Companion animal
- Equine
- Aquaculture
By Route Of Administration
- Subcutaneous
- Intramuscular
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the introduction of new vaccines as one of the prime reasons driving the veterinary vaccines market growth during the next few years. Also, growing number of awareness campaigns and focus on vaccine production capacity expansion will lead to sizable demand in the market.
The report on the veterinary vaccines market covers the following areas:
- Veterinary Vaccines Market sizing
- Veterinary Vaccines Market forecast
- Veterinary Vaccines Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading veterinary vaccines market vendors that include Bayer AG, Biogenesis Bago SA, Biopharm, Biovac Ltd., Bioveta AS, Boehringer Ingelheim International GmbH, Ceva Sante Animale, China Animal Husbandry Industry Co. Ltd, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., HIPRA SA, IDT Biologika GmbH, Indian Immunologicals Ltd., M.C.I Sante Animale, Merck and Co. Inc., Phibro Animal Health Corp., Tianjin ringpu bio-technology Co. Ltd., Vaxxinova International BV, Virbac Group, and Zoetis Inc.. Also, the veterinary vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.